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Abstract
A gold(I)-catalysed reaction of allylic alcohols and phenols produces chromans regioselectively via a one-pot Friedel–Crafts allyl-
ation/intramolecular hydroalkoxylation sequence. The reaction is mild, practical and tolerant of a wide variety of substituents on the
phenol.
Introduction
Chromans (dihydrobenzopyrans) are important and ubiquitous
structural motifs found in a variety of important biologically
active natural products such as vitamin E and flavanoids [1-5].
One approach towards chromans [6-12], which is biosynthetic-
ally inspired, is the Friedel–Crafts allylation [13] of phenols fol-
lowed by cyclisation of the allylated phenol intermediate (via
hydroalkoxylation). Initially, traditional allylating reagents such
as allylic acetates were employed in Friedel–Crafts allylations
[14], but more recently, there has been a distinct drive towards
utilising more environmentally benign allylic alcohols (via a
direct dehydrative coupling strategy) [15,16]. To this end, the
use of molybdenum catalyst CpMoCl(CO)3 together with an
oxidant, o-chloranil, has been documented to catalyse the reac-
tion of allylic alcohols with phenols to form chromans [17,18].
Strong and superacids have also been utilised in the synthesis of
chroman-containing targets [19-21]. Nevertheless, there are still
a few drawbacks with these methods, for example, they usually
require a large excess of substrate (e.g. ~30-fold excess), and in
the case of acid catalysis, also poor yields when the phenol is
not para-substituted. Therefore, it would be desirable to have a
milder method which is compatible with a wide range of substi-
tuted phenols.
As part of our continued interest in developing new gold-cata-
lysed [22-41] reactions [42-51], we have recently shown that
gold(I) can catalyse a direct allylic etherification [52-59] of
unactivated alcohols 2 with unactivated allylic alcohols 1
(Scheme 1, reaction 1) [60,61]. The reaction is mild, regiose-
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Table 1: Initial temperature and equivalents screens, and control reactions.
Entry Equiv 5 Temp. (°C) Catalyst 8 (%) 9 (%) 10 (%)
1 5 50 PPh3AuNTf2 65a - –
2 5 40 PPh3AuNTf2 59b 10b 20b
3 5 30 PPh3AuNTf2 – 66b 27b
4 2 50 PPh3AuNTf2 – 63b 22b
5 1 50 PPh3AuNTf2 – 50b 19b
6 3 60 PPh3AuNTf2 63b – –
7 4 60 PPh3AuNTf2 60b – –
8 5 50 No catalyst – – –
9 5 50 HNTf2 21a – –
10 5 50 AgNTf2 – 70b 25b
aIsolated yield. bYield obtained using 1H NMR analysis with 1,2,4,5-tetrachloro-3-nitrobenzene as internal standard.
lective, and produces only water as a byproduct. During our
studies, a wide range of primary, secondary and tertiary alco-
hols were successfully employed as nucleophiles [61-72], but
our one attempt employing a phenol 5 as a nucleophile surpris-
ingly produced chroman 6 instead (Scheme 1, reaction 2).
Although gold(III)-catalysed Friedel–Crafts allylation of
phenols has been reported by Chan and co-workers [73], there
have been no reports on the direct synthesis of chromans [74]
using gold catalysis [75] with phenols and allylic alcohols prior
to our example shown in Scheme 1.
Scheme 1: Previous work on direct allylic etherification of allylic alco-
hols.
Since the reaction is very practical: distilled solvents and inert
air atmosphere are not required, and the chroman is formed
directly in a mild one-pot procedure with only water as the
byproduct, we decided to investigate the chroman-forming reac-
tion in more detail, beyond the sole example previously
reported (Scheme 1, reaction 2). In this paper, we present our
further studies on this one-pot chroman synthesis: improving
the yield of the desired chroman and exploring the substrate
scope.
Results and Discussion
To commence our studies, we first investigated the possibility
of lowering the reaction temperature and used equivalents of
phenol nucleophile. Suspecting that the moderate yield of 6 in
Scheme 1 is due to the slight volatility of 6, an allylic alcohol 7
with a higher molecular weight was chosen as the model sub-
strate in order to avoid any issues of volatility with the chroman
products. As shown in Table 1, the standard conditions (50 °C,
5 equiv phenol 5) pleasingly provide a good 65% yield of the
desired chroman 8 (Table 1, entry 1). Reducing the temperature
is unfortunately detrimental to the formation of chroman:
40 °C gives a lower 59% yield of 8, as well as Friedel–Crafts
allylation products 9 and 10, whereas 30 °C provides
no chroman 8 at all, instead yielding only Friedel–Crafts
products 9 and 10 (Table 1, entries 2 and 3). The ortho-
and para-Friedel–Crafts products 9 and 10 are formed
via formal SN2' regioselectivity and 9 is presumably the inter-
mediate towards chroman 8 (vide infra). Thus, the higher
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Table 2: Phenol nucleophile scope.
Entry Equiv 5 Temp. (°C) Time (h) Phenol 5 Product Yield (%)a
1 5 50 19
5a 8a
64
2 5 50 64
5b
9b
N/Db
3 5 60 18
5b 8b
57
4 2 60 17
5c
8c and 8c'
71
(~1:1
8c:8c')
5 5 60 18
5d 8d
69
6 5 60 17
5e 8e
63
temperature is clearly necessary to force the in situ cyclisation
of 9 to 8.
Next, lower equivalents of phenol 5 were investigated. Unfortu-
nately, dropping the equivalents of phenol also appears to be
detrimental to chroman formation: only Friedel–Crafts products
9 and 10 are observed with 2 or 1 equivalents of phenol
(Table 1, entries 4 and 5). Pleasingly however, lower equiva-
lents of phenol are tolerated if the temperature is increased to
60 °C (Table 1, entries 6 and 7).
In order to ascertain if the gold(I) catalyst is really necessary for
the formation of chroman 8, several control reactions were
carried out (Table 1, entries 8–10). Firstly, no reaction is
observed in the absence of a catalyst (Table 1, entry 8). The
Brønsted acid catalyst HNTf2 does form chroman 8, but in a
poorer isolated yield (21%, Table 1, entry 9) and the silver salt
[76] AgNTf2 as a catalyst does not provide any 8, yielding only
9 and 10 (Table 1, entry 10). The former is consistent with
literature reports that Brønsted acid-catalysed reactions give
poor yields when the phenol is not para-substituted [19]. There-
fore, it seems that the gold(I) catalyst is most efficient in cata-
lysing the one-pot formation of chroman 8.
With these results in hand, a phenol screen was carried out next
(Table 2). Initially, the same conditions that were best for the
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Table 2: Phenol nucleophile scope. (continued)
7 2 60 17
5f 8f
71
8 2 60 18
5g 8g
54
9 5 60 17
5h 8h
58
10 2 60 17
5i 8i
57
11 5 70 43
5j 8j
83
12c 5 70, 48 h;80, 17 h 65
5k 8k
69
13c,d 5 90 65
5l 8l
83
aIsolated yield. bNot determined. cSolvent: dioxane. dReaction carried out in sealed tube.
formation of 8a were used (50 °C, 5 equiv 5a, Table 2, entry 1)
with p-cresol (5b), but these conditions only produced the
Friedel–Crafts intermediate 9b (Table 2, entry 2). Pleasingly,
when the temperature was raised to 60 °C, the desired chroman
8b is successfully formed in 57% yield (Table 2, entry 3).
Therefore, 60 °C was adopted as the new general conditions
temperature. Additionally, it was found that the equivalents of
phenol 5 can be lowered to 2 equivalents in some cases at this
higher temperature (Table 2, entries 4, 7, 8 and 10). In contrast
to the Brønsted acid procedure [19], the substitution position
has limited effect on the efficiency of the gold-catalysed reac-
tion, with p-cresol (5b), m-cresol (5c) and o-cresol (5d) all
forming the desired chromans 8b–d in decent to good yields
(Table 2, entries 3–5). The regioselectivity of the meta isomer is
unsurprisingly poor (1:1 of 8c:8c'), and when both meta-posi-
tions are substituted (5e) the reaction proceeds to 8e well
(Table 2, entry 6). A phenol with an electron-donating
substituent 5f provides 8f in a good 71% yield (Table 2, entry 7)
and one with an electron-withdrawing substituent 5g pleasingly
also produces chroman 8g in a reasonable 54% yield (Table 2,
entry 8). p-Bromo-substituted phenol 5h successfully yields
chroman 8h which provides a handle for further functionalisa-
tion (Table 2, entry 9).
Next, the effect of a larger substituent was probed (Table 2,
entries 10 and 11). More hindered 2,4-di-tert-butylphenol (5j,
Table 2, entry 11) requires a higher temperature (70 °C) and
twice the reaction time (43 h) to go to completion compared to
4-tert-buylphenol (5i, Table 2, entry 10). Although phenol 5j
exhibits the slowest reactivity of the phenols screened, it was
chosen as the model phenol in the next allylic alcohol substrate
screen (Table 3) since the extra molecular weight from the t-Bu
substituents should reduce any volatility issues with the
chroman products [77].
Beilstein J. Org. Chem. 2013, 9, 1797–1806.
1801
Table 3: Allylic alcohol scope.
Entry Time (h) Temp. (°C) Allylic alcohol Product Yield (%)a
1 43 70
7 8j
83
2 43 60
12
8m
69
3 67 60
4
8n
83
4 42 60
13
8o
64
Figure 1: Initial side product with TMHQ.
At this point, we observed that the general procedure does not
work if the phenol reactant is insoluble in toluene, such as 5k.
However, a simple change of solvent from toluene to dioxane
provides the desired chroman 8k (Table 2, entry 12), although
slightly higher temperatures (70–80 °C) and a longer reaction
time (65 h) are required in this polar solvent to push the reac-
tion to completion.
Finally, to show the synthetic utility of this procedure, a
hydroquinone (trimethylhydroquinone TMHQ (5l)) was also
evaluated, as TMHQ is commonly used towards the synthesis of
vitamin E and its analogues [17,21]. For solubility issues,
dioxane is used as the solvent. Initially, an oxidised side prod-
uct 11 (Figure 1, formed by auto-oxidation of the Friedel–Crafts
intermediate) is observed in 35% yield if the reaction is carried
out in air (80 °C), resulting in a low 45% yield of 8l. When
the reaction vessel is flushed with argon, the yield of 8l
improves to 69%, but ultimately carrying out the reaction at
90 °C in a sealed tube provides a much better yield of 83%
(Table 2, entry 13).
Next, the allylic alcohol scope was investigated (Table 3).
Firstly, going from more hindered Cy substituents (7) to less
hindered n-hexyl substituents (12) allows the reaction to work
smoothly at a lower temperature of 60 °C (Table 3. entries 1
and 2). Hindered 4 works equally well but requires extended
reaction times (67 h) to achieve a good 83% yield (Table 3,
entry 3). Less hindered 13 as well as 14 work smoothly to form
8o and spirocyclic chroman 8p (Table 3, entries 4 and 5). An
aromatic substituent is also well tolerated (Table 3, entry 6).
Next, the effect of substitution along the alkene was investi-
gated (Table 3, entries 7–10). Substitution at the γ-position (16
and 17) seems to be tolerated, forming chromans 8r and 8s re-
spectively albeit in moderate yields (Table 3, entries 7 and 8).
Substitution at the β-position, however, is not tolerated: the
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Table 3: Allylic alcohol scope. (continued)
5 41 60
14 8p
61
6 41 70
15
8q
66
7 43 70
16
8r
45
8 47 70
17
8s
48b
9 42 60
18
9t
35
10 42 60
19
8o
78
11 41 70
20
8u
51
12c 41 60
21
9v
74
aIsolated yield. bApproximately 2:1 d.r. cHeating at 80 °C for 65 h still only gives 9v and no desired chroman.
reaction stops at the Friedel–Crafts stage (9t), and is reluctant to
undergo further cyclisation to the desired chroman (Table 3,
entry 9). Having investigated a series of tertiary allylic alcohols
in entries 1–9, we next looked at selected primary and second-
ary allylic alcohols (Table 3, entries 10–12). The γ,γ-disubsti-
tuted primary allylic alcohol 19 forms the chroman 8o effi-
ciently (Table 3, entry 10), which is the same product as from
the tertiary allylic alcohol substrate 13 in entry 4. This implies
that 19 undergoes the Friedel–Crafts allylation via opposite
regioselectivity (a formal SN2 instead of SN2' observed in all
other examples so far in Table 2 and Table 3) to form 9, fol-
lowed by cyclisation to form the observed 8o. Using a γ,γ-
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Scheme 2: Proposed pathway.
disubstituted secondary allylic alcohol 20 also forms chroman
8u via an initial SN2 Friedel–Crafts regioselectivity, thus γ,γ-
disubstitution on the alkene appears to be responsible for the
switch in regioselectivity (Table 3, entry 11). This implies that
the initial Friedel–Crafts allylation goes via Markovnikov
selectivity. The unsubstituted secondary allylic alcohol 21,
however, produces only the Friedel–Crafts allylation product 9v
and is reluctant to undergo cyclisation to the chroman (Table 3,
entry 12) even under more forcing conditions (80 °C, 65 h).
Since 9 is always observed as a precursor towards 8 (i.e. at
lower temperatures, shorter reactions times or when the reac-
tion is analysed before completion), the most likely mechanism
is the expected gold(I)-catalysed Friedel–Crafts allylation of the
phenol (via Markovnikov regioselectivity), with allylic alcohol
[15,73], followed by cyclisation of the intermediate 9 via
hydroalkoxylation to form chroman 8 (Scheme 2) [13,15,16].
Chan and co-workers have previously proposed that the
Friedel–Crafts mechanism could involve the activation of the
allylic alcohol by the gold catalyst to turn the hydroxy group
into a better leaving group [73]. The observed regioselectivities
is then due to the subsequent attack at the less hindered pos-
ition of this presumed activated intermediate [73,78].
Our subsequent investigations with the Friedel–Crafts inter-
mediate 9a suggests that the second hydroalkoxylation step is
not (or not solely) gold catalysed (Scheme 3). When isolated 9a
is resubjected to the reaction conditions with or without add-
itional phenol (5a), no cyclisation to the chroman 8a occurs
(Scheme 3). Thus, the second cyclisation step is most likely
Brønsted acid catalysed (or acid and gold(I) co-catalysed) [79],
where the H+ required is being released in situ during the first
Friedel–Crafts step to form 9. This would explain why 9 readily
cyclises to chroman 8 in situ, but is reluctant to do so when it is
isolated before being resubjected to more gold(I) catalyst, as in
Scheme 3. Nevertheless, simply using the equivalent Brønsted
acid HNTf2 is not as efficient as using gold(I), as shown in
Table 1, entry 9.
If the hydroalkoxylation step is indeed H+ catalysed, addition of
a Brønsted acid co-catalyst could force the chroman formation
from substrates such as 21, which do not undergo the second
hydroalkoxylation step under just gold(I)-catalysed conditions
Scheme 3: Control reactions.
(Table 3, entry 12). Indeed, the reaction of 21 with 5j success-
fully produces the desired chroman 8v in 52% yield when
HNTf2 is added as a co-catalyst (Scheme 4), further suggesting
that the hydroalkoxylation step is most likely Brønsted acid
catalysed or co-catalysed.
Scheme 4: Reaction of 21 with added Brønsted acid co-catalyst.
The suggested mechanism is presented in Scheme 5. Gold(I)
catalysts are known to coordinate to alcohols [80], in this case
turning the hydroxy group into a better leaving group (I), as
previously suggested by Chan [73]. Attack at the less hindered
position could occur either directly on I [SN2' shown, but in the
case of γ,γ-disubstituted substrates (e.g. 19 and 20), this will
occur via SN2] or via an allylic cation intermediate II. The
intermediate 9 subsequently undergoes an acid-catalysed
hydroalkoxylation to produce the desired chroman 8. Active
catalyst LAu+ is presumably regenerated by protonolysis of
LAuOH [81].
Conclusion
In conclusion, a simple one-pot procedure towards chromans is
described via gold(I)-catalysed reaction of readily accessible
phenols with allylic alcohols. This one-pot procedure involves a
regioselective Friedel–Crafts allylation followed by cyclisation
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Scheme 5: Suggested mechanism.
via hydroalkoxylation to form the chromans in good yields. At
lower temperatures or shorter reaction times, the Friedel–Crafts
allylation intermediates are usually observed. The reaction
works with ortho-, meta- and para-substituents as well as elec-
tron donating and withdrawing substituents on the phenol, and
hydroquinones (Table 2). A variety of allylic alcohol substrates
work well, although substitution on the alkene is only tolerated
at the γ-position, and not the β-position (Table 3). The
procedure is mild, practically simple and regioselective. We
therefore believe that it should find utility as a convenient
method towards the synthesis of chroman targets.
Experimental
General procedure: The gold-catalysed reactions were all
carried out in 1 dram screw-cap vials without the need for
distilled solvents or inert atmosphere, unless otherwise stated.
PPh3AuNTf2 (5 mol %) was added to a toluene solution
(0.386 M) of allylic alcohol (1 equiv) and phenol (2 or 5 equiv).
The reaction mixture was allowed to stir at 50–70 °C until the
reaction is complete (16–67 h). The reaction was then filtered
through a plug of silica (eluent: neat diethyl ether). The filtrate
was concentrated under reduced pressure, and 1H NMR analysis
of the crude mixture was used to determine the conversion to
chroman 8. The crude material was then purified by flash
column chromatography. [Note: If the starting materials are
insoluble in toluene, dioxane is used as the solvent instead and
the reaction temperature increased to 70–80 °C.]
Supporting Information
Supporting Information File 1
Full experimental procedures, characterisation for all new
compounds and copies of 1H and 13C NMR spectra.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-9-209-S1.pdf]
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